# Novavax Inc: filings

NVAX · Nasdaq · CIK 1000694 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nvax.md) · [Financials](/companies/nvax/financials.md) · [Filings](/companies/nvax/filings.md) · [Insiders](/companies/nvax/insiders.md)

## Reports and events: 382 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 549, 8-K 269, 10-Q 53, SC 13G/A 49, 3 31, 424B5 28, DEFA14A 20, DEF 14A 19, 10-K 18, SC 13G 18, UPLOAD 17, S-8 16, 4/A 15, CORRESP 15, CT ORDER 14, 144 10, PRE 14A 7, 8-K/A 6, ARS 6, EFFECT 6, DFAN14A 5, S-3 5, SC 13D/A 5, SCHEDULE 13D/A 5, 10-K/A 3, 425 3, S-3ASR 3, SC 13D 3, DEFR14A 2, NT 10-K 2, S-3/A 2, SCHEDULE 13G 2, SCHEDULE 13G/A 2, 10-Q/A 1, 144/A 1, 424B2 1, 424B7 1, CB 1, FWP 1, NT 10-Q 1, PREC14A 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:30 ET | [8-K](/filings/0001104659-26-120221.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-120221 |
| 2026-10-16 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001398344-26-018323.md) | Ownership report, active investor, amended | 0001398344-26-018323 |
| 2026-08-06 | 08:03 ET | [8-K](/filings/0001000694-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-26-000019 |
| 2026-08-06 | 07:50 ET | [10-Q](/filings/0001000694-26-000018.md) | Quarterly report, period 2026-06-30 | 0001000694-26-000018 |
| 2026-06-23 | 08:00 ET | [8-K](/filings/0001104659-26-076648.md) | 5.07 Shareholder vote results | 0001104659-26-076648 |
| 2026-05-15 | 08:15 ET | [SCHEDULE 13D/A](/filings/0001398344-26-009210.md) | Ownership report, active investor, amended | 0001398344-26-009210 |
| 2026-05-06 | 08:00 ET | [8-K](/filings/0001628280-26-030924.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030924 |
| 2026-05-06 | 07:50 ET | [10-Q](/filings/0001628280-26-030917.md) | Quarterly report, period 2026-03-31 | 0001628280-26-030917 |
| 2026-04-27 | 08:00 ET | [DEF 14A](/filings/0001628280-26-027328.md) | Proxy statement, period 2026-06-18 | 0001628280-26-027328 |
| 2026-04-08 | 06:00 ET | [SCHEDULE 13D/A](/filings/0001398344-26-006235.md) | Ownership report, active investor, amended | 0001398344-26-006235 |
| 2026-02-26 | 08:02 ET | [8-K](/filings/0001000694-26-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-26-000011 |
| 2026-02-26 | 07:33 ET | [10-K](/filings/0001000694-26-000007.md) | Annual report, period 2025-12-31 | 0001000694-26-000007 |
| 2026-01-20 | 06:59 ET | [8-K](/filings/0001104659-26-004785.md) | 1.01 Entry into a material agreement | 0001104659-26-004785 |
| 2026-01-12 | 08:01 ET | [8-K](/filings/0001104659-26-002725.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002725 |
| 2025-11-12 | 16:17 ET | [SCHEDULE 13D/A](/filings/0001398344-25-020786.md) | Ownership report, active investor, amended | 0001398344-25-020786 |
| 2025-11-06 | 08:00 ET | [8-K](/filings/0001000694-25-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-25-000048 |
| 2025-11-06 | 07:47 ET | [10-Q](/filings/0001000694-25-000046.md) | Quarterly report, period 2025-09-30 | 0001000694-25-000046 |
| 2025-11-04 | 06:02 ET | [8-K](/filings/0001104659-25-105818.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-105818 |
| 2025-10-22 | 07:00 ET | [8-K](/filings/0001104659-25-101390.md) | 1.01 Entry into a material agreement; 2.06 Material impairments; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-101390 |
| 2025-10-14 | 07:45 ET | [SCHEDULE 13D/A](/filings/0001398344-25-019099.md) | Ownership report, active investor, amended | 0001398344-25-019099 |
| 2025-10-07 | 07:00 ET | [8-K](/filings/0001104659-25-097317.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-097317 |
| 2025-08-27 | 16:40 ET | [8-K](/filings/0001104659-25-084053.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-084053 |
| 2025-08-27 | 16:38 ET | [8-K](/filings/0001104659-25-084049.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-084049 |
| 2025-08-21 | 07:48 ET | [8-K](/filings/0001104659-25-081160.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-081160 |
| 2025-08-06 | 08:04 ET | [8-K](/filings/0001000694-25-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-25-000031 |
| 2025-08-06 | 07:47 ET | [10-Q](/filings/0001000694-25-000029.md) | Quarterly report, period 2025-06-30 | 0001000694-25-000029 |
| 2025-06-24 | 06:03 ET | [8-K](/filings/0001104659-25-061874.md) | 5.07 Shareholder vote results | 0001104659-25-061874 |
| 2025-06-11 | 07:01 ET | [8-K](/filings/0001104659-25-058379.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-058379 |
| 2025-05-27 | 16:05 ET | [8-K](/filings/0001104659-25-052959.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-052959 |
| 2025-05-19 | 07:34 ET | [8-K](/filings/0001104659-25-050226.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001104659-25-050226 |
| 2025-05-08 | 08:26 ET | [8-K](/filings/0001000694-25-000024.md) | 2.02 Results of operations | 0001000694-25-000024 |
| 2025-05-08 | 07:59 ET | [10-Q](/filings/0001000694-25-000021.md) | Quarterly report, period 2025-03-31 | 0001000694-25-000021 |
| 2025-05-05 | 09:25 ET | [8-K](/filings/0001104659-25-044372.md) | 1.01 Entry into a material agreement | 0001104659-25-044372 |
| 2025-04-29 | 08:51 ET | [DEF 14A](/filings/0001000694-25-000013.md) | Proxy statement, period 2025-06-20 | 0001000694-25-000013 |
| 2025-04-29 | 08:00 ET | [8-K](/filings/0001104659-25-040656.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-040656 |
| 2025-04-23 | 08:00 ET | [8-K](/filings/0001104659-25-037728.md) | 7.01 Regulation FD disclosure | 0001104659-25-037728 |
| 2025-04-02 | 14:52 ET | [8-K](/filings/0001104659-25-031099.md) | 7.01 Regulation FD disclosure | 0001104659-25-031099 |
| 2025-03-11 | 16:45 ET | [8-K](/filings/0001104659-25-022588.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-022588 |
| 2025-03-11 | 08:30 ET | [8-K](/filings/0001104659-25-022435.md) | 1.02 Termination of a material agreement | 0001104659-25-022435 |
| 2025-03-04 | 08:01 ET | [8-K](/filings/0001104659-25-020023.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-020023 |
| 2025-02-27 | 08:05 ET | [8-K](/filings/0001000694-25-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-25-000006 |
| 2025-02-27 | 07:41 ET | [10-K](/filings/0001000694-25-000004.md) | Annual report, period 2024-12-31 | 0001000694-25-000004 |
| 2025-01-13 | 07:50 ET | [8-K](/filings/0001104659-25-002863.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002863 |
| 2024-12-30 | 17:27 ET | [8-K](/filings/0001104659-24-132569.md) | 2.01 Completion of an acquisition or disposition | 0001104659-24-132569 |
| 2024-12-18 | 17:24 ET | [8-K](/filings/0001104659-24-129823.md) | 1.01 Entry into a material agreement | 0001104659-24-129823 |
| 2024-12-04 | 06:00 ET | [8-K](/filings/0001104659-24-125265.md) | 1.01 Entry into a material agreement | 0001104659-24-125265 |
| 2024-11-20 | 20:01 ET | [8-K](/filings/0001104659-24-120698.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-120698 |
| 2024-11-12 | 16:08 ET | [10-Q](/filings/0001000694-24-000043.md) | Quarterly report, period 2024-09-30 | 0001000694-24-000043 |
| 2024-11-12 | 11:21 ET | [8-K](/filings/0001104659-24-116593.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-116593 |
| 2024-11-12 | 08:04 ET | [8-K](/filings/0001000694-24-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-24-000040 |

Page 1 of 8. [Older](/companies/nvax/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:32 ET. No prices; not investment advice.